JDRF (The Juvenile Diabetes Research Foundation)
Signal active
Investment Firm
Overview
JDRF is a global organization dedicated to funding type 1 diabetes (T1D) research. The organization offers grants for diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research companies.
JDRF was founded in 1970 and is headquartered in New York City with an additional office in Houston, Texas.
Highlights
Founded
1970
Industry
Health Care
Employees
501-1000
Investment
9
Lead Investment
4
Exits
2
Stages
Early Stage Venture
Investor Type
N/A
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
JDRF (The Juvenile Diabetes Research Foundation), established in Unknown year and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture investments across Biotechnology, Health Care, Financial Services, Venture Capital, Finance, Business Development, Life Science, Medical, Therapeutics, Diabetes. The organization boasts a portfolio of 9 investments, with an average round size of $4.1M and 2 successful exits. Their recent investments include AnTolRx, Pfizer Venture Investments, Orion Healthcare Equity Partners, ViaCyte, W.L. Gore & Associates. The highest investment round they participated in was $710.7M. Among their most notable exits are AnTolRx and Pfizer Venture Investments. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
JDRF (The Juvenile Diabetes Research Foundation) has made 9 investments. Their most recent investment was on Apr 04, 2023, when Diamyd Medical raised $5.0M.
JDRF (The Juvenile Diabetes Research Foundation) has made 1 diversity investments. Their most recent diversity investment was on Dec 14, 2018, when TidePool raised $6.0M.
investments
9
Diversity investments
1
Lead investments
4
Number of exits
2
Investments
9
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jun 03, 2022 | Neurodon | Biotechnology | 920.0K |
| Apr 04, 2023 | Diamyd Medical | Biotechnology | 5.0M |
| Jun 15, 2023 | - | - | 2.0M |
| Jun 22, 2023 | Diatech Diabetes | Health Care | null |
Diamyd MedicalExits
2
Funding Timeline
Funding rounds
9
Investors
0
Funds
1
Funding Rounds
9
JDRF (The Juvenile Diabetes Research Foundation) has raised 9 rounds. Their latest funding was raised on Jun 22, 2023 from a Grant - Diatech Diabetes round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jun 03, 2022 | Grant - Neurodon | - | 920.0K | - |
| Apr 04, 2023 | Grant - Diamyd Medical | - | 5.0M | - |
| Jun 15, 2023 | Grant - Zucara Therapeutics | - | 2.0M | - |
| Jun 22, 2023 | Grant - Diatech Diabetes | - | 0 | - |
Investors
1
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
| - | No | Grant - JDRF (The Juvenile Diabetes Research Foundation) | 3.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
Funding Round
Jun 22, 2023
Diatech Diabetes raised an undisclosed amount on 2023-06-22 in Grant
Funding Round
Jun 15, 2023
Zucara Therapeutics raised $2000000 on 2023-06-15 in Grant
Funding Round
Apr 04, 2023
Diamyd Medical raised $5000000 on 2023-04-04 in Grant
Funding Round
Jun 03, 2022
Neurodon raised $920000 on 2022-06-03 in Grant
Funding Round
Dec 14, 2018
TidePool raised $6000000 on 2018-12-14 in Grant